- Project Name Healthcare Investment
- Returns Income Option: 9.5% {12 months} - 12% {24 months} ROI Per Annum
- Fully Secured Investment
- Growth Option
- 12 Months Fixed Term Investment
- Convertible Option: Converting your Loan Note to Equity by month 18 will give you a 15% discount on the valuation
Project Summary
The company is developing its vertically integrated Medical cannabis business and is approved by INFARMED to start the implementation process for medicinal cannabis cultivation, import and export in the European country of Portugal. The business was incorporated in 2017 in Portugal, with a focus on the large-scale supply of medical grade cannabis oil for retail to Pharmaceuticals, National Health Services and cannabis production companies throughout the EU.
The company has positioned itself with the largest cultivation site within the European Union. Their goal for its first year will be to supply the EU market with quality, low cost product to fill the void left from the short supply of medical cannabis.
First year’s harvest will be cultivated on 20 hectares of the 95 (45%) Hectare site. In order to do so, the company requires the funds to develop the site; this includes completing the option for the land, security of the site and building out the GMP production facility and OPEX. This development will progress over the first 12 months, until the first crop cycle has been completed.
